ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

TVGNW Tevogen Bio Holdings Inc

0.0195
0.0023 (13.37%)
27 6월(6) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Tevogen Bio Holdings Inc TVGNW 나스닥 주식 인수형 워런트
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.0023 13.37% 0.0195 09:00:00
개장가 저가 고가 종가 전일 종가
0.0172 0.01405 0.0195 0.0195 0.0172
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
27/06/202401:46GLOBETevogen Bio Files Registration Statement for Previously..
25/06/202421:05GLOBETevogen Bio Announces Publication of Positive Phase I..
19/06/202404:17GLOBETevogen.AI Head Discusses Company’s Bold Strategy to Shape..
14/06/202405:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/06/202404:45GLOBETevogen Bio Set to Join Russell 3000® Index
12/06/202405:30EDGAR2Form 8-K - Current report
12/06/202404:30GLOBETevogen Bio Enters Into Agreement for Up to $50 Million in..
08/06/202405:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/06/202404:32GLOBECORRECTION – Tevogen Bio Expresses Gratitude to Patients,..
07/06/202407:14GLOBETevogen Bio Expresses Gratitude to Patients, First..
07/06/202404:52GLOBETevogen Bio Confirms Ongoing Efficacy of TVGN 489, Its..
31/05/202405:30EDGAR2Form 8-K/A - Current report: [Amend]
29/05/202421:00GLOBETevogen Bio Reports First Quarter 2024 Financial Results
29/05/202406:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
17/05/202406:01EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
17/05/202405:52EDGAR2Form 8-K - Current report
17/05/202403:00GLOBETevogen Bio Appoints Former Police Chief & FBI National..
11/05/202406:40GLOBETevogen Bio Announces Up to $50 Million in Financing to..
01/05/202421:05GLOBETevogen Bio Announces Full Year 2023 Financial Results and..
26/04/202422:23GLOBETevogen Bio CEO Highlights Expected Reporting of a $94.9..
11/04/202421:05GLOBETevogen Bio’s Chief Scientific Officer Speaks on the..
03/04/202421:05GLOBETevogen Bio Appoints Tapan V Shah as Head of Investor..
28/03/202421:05GLOBETevogen Bio Reports Series A-1 Preferred Stock Investment at..